Loxo Oncology(LOXO)

LOXO vs RXDX: 破解市值差异之谜

淘沙见金2017-06-11 02:12

谁是2017年ASCO大会的明星？答案肯定是Loxo Oncology($Loxo Oncology(LOXO)$)。在公布完其针对TRK融合基因治疗罕见肿瘤在研药物larotrectinib（LOXO-101）的二期临床数据之后，公司市值翻了近乎一倍，将其竞争对手Ignyta ($IGNYTA INC(RXDX)$ ) 远远甩在身后。目前Ignyta的市值大概在4亿左右，大概...查看全文

Just-a-Novice2017-06-10 02:38

今天，如果不算DCTH这类跟基本面基本无关的纯day trade，在大公司里，做了三笔short：
$阿里巴巴(BABA)$ 从148下来，$Twilio(TWLO)$ 从25.6下来，$Loxo Oncology(LOXO)$ 又一次从77short下来。
看着这三个同时开始加速下跌，好有成就感~ 这成就感的来源，和赚钱本身无关，而是来自于，逐...查看全文

Just-a-Novice2017-06-05 21:33

$Loxo Oncology(LOXO)$
Shorted at 77.
Set Stop at 75.查看全文

船长Captain092015-11-17 08:23

$Loxo Oncology(LOXO)$恶性肿瘤的小分子靶向疗法，走得很稳健了查看全文

我是_一级棒2015-06-21 07:59

$Loxo Oncology(LOXO)$ Catalysts: LOXO expects to release their first data - the Phase1a data, with initiation of the Phase1b expansion in Q2 15, and an IND for their 1st of many undisclosed compounds in 2H 15. （信息资料仅供分享只用，买卖前需平衡自身风险承受能力）查看全文

我是_一级棒2015-06-20 04:08

$Loxo Oncology(LOXO)$ finished +25% on 2nd week after breakout 15.5查看全文

我是_一级棒2015-06-10 08:16

$Loxo Oncology(LOXO)$ weekly map...... drive to $25 - $35?查看全文

我是_一级棒2015-06-08 21:10

$Loxo Oncology(LOXO)$ 2013年的IPO，很少人关注的一个cancer股，10个月的IPO base，15.5是突破位，可以关注一下。查看全文

斗斗娃娃2014-09-05 22:17

$Loxo Oncology(LOXO)$ 涨起来了查看全文

$Loxo Oncology(LOXO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-20-003307  Act: 34  Size: 10 KB 网页链接

$Loxo Oncology(LOXO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-20-000048  Act: 34  Size: 32 KB 网页链接

$Loxo Oncology(LOXO)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2019-02-25 AccNo: 0001193125-19-049296 Size: 10 KB 网页链接

$Loxo Oncology(LOXO)$ EFFECT - Notice of Effectiveness Filed: 2019-02-21 AccNo: 9999999995-19-000306 Size: 1 KB 网页链接

$Loxo Oncology(LOXO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-02-15 AccNo: 0000950142-19-000290 Size: 146 KB 网页链接

$Loxo Oncology(LOXO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-02-15 AccNo: 0001193125-19-042490 Size: 18 KB 网页链接

$Loxo Oncology(LOXO)$ POSASR - Post-effective Amendment to an automatic shelf registration statement Filed: 2019-02-15 AccNo: 0001193125-19-042498 Size: 18 KB 网页链接

$Loxo Oncology(LOXO)$ 8-K - Current report Filed: 2019-02-15 AccNo: 0001193125-19-042505 Size: 114 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem...

$Loxo Oncology(LOXO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-15 AccNo: 0001193125-19-042509 Size: 26 KB 网页链接

$Loxo Oncology(LOXO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-15 AccNo: 0001193125-19-042519 Size: 26 KB 网页链接